Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

Peer Review reports

Original Submission
20 Jan 2012	Submitted	Original manuscript
3 Mar 2012	Reviewed	Reviewer Report - Dirk Vordermark
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
23 Mar 2012	Editorially accepted
23 Mar 2012	Article published	10.1186/1471-2407-12-112

Back to article page